CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
- PMID: 34863742
- PMCID: PMC8634688
- DOI: 10.1016/j.scitotenv.2021.152072
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
Abstract
The combat against the Corona virus disease of 2019 (COVID-19), has created a chaos among the healthcare institutions and researchers, in turn accelerating the dire need to curtail the infection spread. The already established entry mechanism, via ACE2 has not yet successfully aided in the development of a suitable and reliable therapy. Taking in account the constant progression and deterioration of the cases worldwide, a different perspective and mechanistic approach is required, which has thrown light onto the cluster of differentiation 147 (CD147) transmembrane protein, as a novel route for SARS-CoV-2 entry. Despite lesser affinity towards COVID-19 virus, as compared to ACE2, this receptor provides a suitable justification behind elevated blood glucose levels in infected patients, retarded COVID-19 risk in women, enhanced susceptibility in geriatrics, greater infection susceptibility of T cells, infection prevalence in non-susceptible human cardiac pericytes and so on. The manuscript invokes the title role and distribution of CD147 in COVID-19 as an entry receptor and mediator of endocytosis-promoted entry of the virus, along with the "catch and clump" hypothesis, thereby presenting its Fundamental significance as a therapeutic target for potential candidates, such as Azithromycin, melatonin, statins, beta adrenergic blockers, ivermectin, Meplazumab etc. Thus, the authors provide a comprehensive review of a different perspective in COVID-19 infection, aiming to aid the researchers and virologists in considering all aspects of viral entry, in order to develop a sustainable and potential cure for the 2019 COVID-19 disease.
Keywords: ACE2; CD147; COVID-19; Catch and clump; Melatonin; Receptor.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
![Unlabelled Image](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683f/8634688/5212c1ed9788/ga1_lrg.gif)
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683f/8634688/fb9a4e3aa63b/gr1_lrg.gif)
![Fig. 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683f/8634688/ab21333f3e65/gr2_lrg.gif)
![Fig. 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683f/8634688/004e43fbc3e8/gr3_lrg.gif)
Similar articles
-
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.Signal Transduct Target Ther. 2020 Dec 4;5(1):283. doi: 10.1038/s41392-020-00426-x. Signal Transduct Target Ther. 2020. PMID: 33277466 Free PMC article.
-
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.mSphere. 2021 Aug 25;6(4):e0064721. doi: 10.1128/mSphere.00647-21. Epub 2021 Aug 11. mSphere. 2021. PMID: 34378982 Free PMC article.
-
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.Stem Cell Rev Rep. 2020 Jun;16(3):434-440. doi: 10.1007/s12015-020-09976-7. Stem Cell Rev Rep. 2020. PMID: 32307653 Free PMC article. Review.
-
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.Clin Sci (Lond). 2021 Dec 22;135(24):2667-2689. doi: 10.1042/CS20210735. Clin Sci (Lond). 2021. PMID: 34807265 Free PMC article.
-
Tumor markers as an entry for SARS-CoV-2 infection?FEBS J. 2020 Sep;287(17):3677-3680. doi: 10.1111/febs.15499. Epub 2020 Aug 28. FEBS J. 2020. PMID: 32738184 Free PMC article. Review.
Cited by
-
The interplay of aging, adipose tissue, and COVID-19: a potent alliance with implications for health.Geroscience. 2024 Jun;46(3):2915-2932. doi: 10.1007/s11357-023-01058-z. Epub 2024 Jan 8. Geroscience. 2024. PMID: 38191833 Free PMC article. Review.
-
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis.Cureus. 2023 Dec 17;15(12):e50703. doi: 10.7759/cureus.50703. eCollection 2023 Dec. Cureus. 2023. PMID: 38234925 Free PMC article. Review.
-
Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology.Front Med (Lausanne). 2024 Sep 20;11:1428973. doi: 10.3389/fmed.2024.1428973. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39371335 Free PMC article.
-
Biological effects of COVID-19 on lung cancer: Can we drive our decisions.Front Oncol. 2022 Oct 10;12:1029830. doi: 10.3389/fonc.2022.1029830. eCollection 2022. Front Oncol. 2022. PMID: 36300087 Free PMC article. Review.
-
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.Life Sci. 2022 Apr 1;294:120368. doi: 10.1016/j.lfs.2022.120368. Epub 2022 Jan 30. Life Sci. 2022. PMID: 35108568 Free PMC article. Review.
References
-
- Adikwu E., Ebinyo N.C., Bokolo B. Melatonin and alpha lipoic acid attenuate methotrexate/cisplatin-induced kidney toxicity in albino rats. J. Nephropharmacol. 2020;9 doi: 10.15171/npj.2020.17. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous